Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial.
Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Götz A, Holm K, Aukrust P, Åkra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Trøseid M, Broch K.
Awoyemi A, et al.
EBioMedicine. 2021 Aug;70:103511. doi: 10.1016/j.ebiom.2021.103511. Epub 2021 Jul 28.
EBioMedicine. 2021.
PMID: 34329947
Free PMC article.
Clinical Trial.